Try our Advanced Search for more refined results
Life Sciences - October, 2023
365 articles
- New Jersey Gov. Fumes As Orsted Drops Wind Farm Projects
- Conn. AG Presses 23andMe Over User Data Breach
- Here's What's To Come In Fight Over Apple Watch Import Ban
- Mich. AG Says Christian Clinic Can't Bolster Record In Appeal
- 6th Circ. Asked To Step Into Opioid Special Master Row
- Dem. Sens. Urge Biden Admin. To Cover OTC Birth Control
- Weight Loss Drug Developer Files For Liquidation
- 3rd Circ. Presses For Evidence In Merck Shingles Vax Suit
- ITC Won't Review Decision In Biomolecular Patent Fight
- GoodRx Privacy Deal Sets Milberg Fees At Up To $4.5M
- Munger Tolles Fights DQ Bid In GenapSys' Paul Hastings Suit
- What To Know About The White House's Sweeping AI Directive
- PCBs Didn't Cause Brain Damage In Wash. Case, Jury Told
- 9th Circ. Reopens Providers' Challenge To Ariz. Abortion Law
- Vidal Urges Input On Invalidating Patents For Misconduct
- Justices Refuse To Take Up Maine Hospital Workers' Vax Suit
- Eli Lilly Tries To Nix Claims In Mounjaro Failure-To-Warn Suit
- 3rd Circ. Says Janssen Can't Appeal DTSA Seizure Order
- Co., CEO Who Defended 'Pharma Bro' Reach $50M FCA Deal
- Medical School Supervisors Accused Of 'Conspiratorial Cabal'
- ESG Around The World: The UK
- Microscope Equipment Maker's Trade Secrets Suit Narrowed
- Boeing Opinion Strikes Blow Against Overpayment Theory
- Health Systems Say Meta Data-Sharing Suit Lacks Substance
- Tips For Litigating Against Pro Se Parties In Complex Disputes
- Gene Therapy-Focused Lexeo Therapeutics Eyes $126M IPO
- High Court Asks Apple To Chime In On Time Limit At PTAB
- Rush University Hospital Sued Over Worker Fingerprint Scans
- Are Justices Split 3-3-3? New Term Is Already Offering Clues
- Pharmacy Wants Out Of Eli Lilly Diabetes Drug Suit
- 3M Looks To Pause Warming Device Defense Coverage Row
- 6th Circ. Urged To Preserve Faith-Based Hiring Exemption
- Texas Pharmacy Owner Convicted In $55M Fraud Scheme
- What Pharma Cos. Must Know About FDA Off-Label Guidance
- 9th Circ. Kicks Psilocybin Rescheduling Petition To DEA
- Bayer, Janssen Sue Taro Over Xarelto Generic
- 3M Polluted Delaware With PFAS, Hid Harm, State AG Alleges
- Biotech Firm Rips 'Time-Worn Cudgel,' Wants Attys Punished
- Warrants In Pfizer Insider-Trading Case Fair Game, Feds Say
- Gilead Judge Leery Of Drug Buyers' New Antitrust Trial Bid
- Amyris Creditor Claims Doerr Schemed To Seize IP
- 1st Circ. OKs Immunity To Officials In Workers' COVID-19 Suit
- Satanic Temple Can't Challenge Indiana Abortion Ban
- How Mike Johnson Stands On 3 Key Health Care Policy Issues
- Apple Gets PTAB To Ax Bulk Of AliveCor Heart Monitor Claims
- Pear Therapeutics Wants More Time To File Ch. 11 Plan
- Monsanto Spinoff's Expert Says PCB Plaintiffs Look Healthy
- Emcure Again Looks To Toss HDT's $950M Trade Secrets Suit
- Laser Co. Ends TM Suit Over Rival's Celebrity Laser Treatment
- Veterinary Stem Cell Patent Case Settles Days Before Trial
- Ex-Stimwave Director Wants Company To Pay His Legal Bills
- ITC Bans Apple Watch Imports In Masimo Patent Case
- Sofinnova Partners Closes $200M Digital Medicine Fund
- It's Time To Prescribe Frameworks For AI-Driven Health Care
- Mass. Biotech Clinches $92M Series A Funding Round
- Cannabis Operators Say Federal Ban Is Unconstitutional
- Bayer Fights Bid To Toss $12M Benzene Contamination Suit
- The Murky World Of IP Protection For Gene-Edited Plants
- Pa. Court Inks $15M Judgment Against Defunct Cannabis Co.
- Novartis Should Face Gender Bias Case, Judge Says
- Shutts & Bowen Adds Leading Anti-Abortion Atty To Its Ranks
- Penile Implant Doc Deserves $46M After Trial Win, Judge Told
- US Trustee Balks At 5% Breakup Fee In Zymergen Bid
- Ecolab, DuBois Dueling Bids Mostly Rejected In Patent Row
- First Nations Group Asks High Court To Nix Sackler Releases
- PTAB Largely Invalidates Patent In UV Sanitation Fight
- FDA Plans Tighter Scrutiny Of Off-Label Data Sent To Doctors
- 6th Circ. Eyes Reviving Little Debbie Maker's ERISA Fight
- Novartis Sues Takeda To Address Possible IP Theft
- FTC, Illumina Say EU Unwinding Order Won't Impact Appeal
- Drug Cos. Question When Reissued Patent Is Actually Issued
- FDA Will Review AstraZeneca Nasal Spray Flu Vaccine
- New Initiatives Will Advance Corporate Biodiversity Reporting
- 'Concerning Error' Dooms SEC Case Against Zicam Inventor
- FTC Halts Marketing Of 'Invisible' Anti-COVID Mask
- Medical Lab Co. Wants Managers Out Of Wage Dispute
- Amyris Noteholders Tag Doerr In Ch. 11 Discovery Push
- Alternative Patents Would Solve Many Inventor Woes
- Class Action Defense: Don't Give Up On Bristol-Myers Squibb
- Ga. Doc Appeals $27.5M Judgment In False Billing Scheme
- Biden's Pick For NIH Director Advances With GOP Support
- Pro Bono Work Is Powerful Self-Help For Attorneys
- Judge Rips 'Nonsensical' Class Action Over P&G Supplement
- Monsanto Resolves Claims It Excluded Farmworker From Deal
- Kristen Bell's Baby Co. Gets Interim OK For $47M DIP In Ch. 11
- Dialysis Cos. Settle Double-Billing Allegations For $9.5M
- Patent Office Raises IP Questions For Tribes
- Sotera Solidifies Masimo Patent Wipeout With Fed. Circ. Win
- Startups Take Lead On Some COVID-19 Patents
- HHS 'Coerces' Abortion Stance With Title X Loss, Tenn. Says
- Insurer Used 'Legal Loopholes' To Avoid Payments, Court Told
- FDA Proposals Clarify Rules For Devices With Predicates
- State Regs Sow Discord Between Cannabis, Hemp Industries
- Gunderson Dettmer Advises OrbiMed In $4.3B Fund Round
- Med-Tech Co. UpHealth And 6 Units Get OK For Joint Ch. 11
- Malpractice Row Is 'Groundhog Day,' Texas Justices Told
- Playing In A Rock Cover Band Makes Me A Better Lawyer
- AI May Help Patent Applicants With Functional Claiming
- Ga. Abortion Ban Not Voided By Roe, State Justices Rule
- Wyrick Robbins Guiding Citius Oncology Unit In SPAC Merger
- Roche And Biogen Settle Patent Row Over Arthritis Biosimilar
- Boston Scientific Valve Recall Sparks Shareholder's Del. Suit
- HHS Says Texas' Abortion Pill Guidance Fight Is Moot
- Kansas Judge Nixes Product-Liability Suit Over Huffing Death
- Medicare Drug Price Talks Boon For Public Health, Court Told
- Flint Expert Barred From Discussing Lead's Effect On Fetuses
- Inventors Face 'Tough Love' From PTAB Critics On Politics
- 10x Dodges Inter Partes Review In Split PTAB Decision
- How Int'l Regulatory Collabs Can Expedite Pharma Approvals
- 10 Charged With $20M Black Market HIV Drug Fraud Scheme
- How Executives' Deposition Standards Can Differ
- High Court Told Purdue's Ch. 11 Liability Waiver Is Legal
- Goodwin Adds Ropes & Gray Life Sciences Pro In China, Calif.
- Catching Up With Delaware's Chancery Court
- The Pop Culture Docket: Judge Espinosa On 'Lincoln Lawyer'
- 1315 Capital Lands $500M Across 2 Health Care Funds
- Icahn Says $8B Illumina-Grail Deal Caused Millions In Losses
- Calif. GHG Disclosure Law Will Affect Companies Worldwide
- Kristen Bell's Hollywood Diaper Co. Hello Bello Hits Ch. 11
- 23andMe Exposed Ashkenazi Jews' Data In Breach, Suit Says
- SG Wants Ch. 11 Carve-Out Cases Stalled Until Purdue Ruling
- DEA Process For Drug Rescheduling Unlawful, 9th Circ. Hears
- Market Headwinds And Geopolitical Risks Muddle IPO Plans
- Questions Linger After FDA's Lab-Developed Tests Proposal
- Lessons For Biosimilar And Biologic Antitrust Litigation
- Supplement Co. Owners Must Post Bond To Stay TM Penalty
- Crowell Says Walgreens Is 'Sandbagging' In Humana Suit
- Health Care Tech Co.'s Atty Moves Firing Suit To NY Fed. Court
- Balancing Justice And Accountability In Opioid Bankruptcies
- MVP: Winston & Strawn's George Lombardi
- UK Litigation Roundup: Here's What You Missed In London
- Gateley Hires Clifford Chance Duo To Head Arbitration Team
- 4 Firms Guide French Biotech Firm Abivax's $236M US IPO
- European Commission Issues 1st Ever Pharma Cartel Fine
- Taxation With Representation: Skadden, Cravath, Latham
- Altria Unit Says Dozens Of Vape Makers Sell Illegal Products
- SEC Says Jury Should Hear First 'Shadow Trading' Case
- 9th Circ. To Hear Args In Psilocybin Rescheduling Challenge
- House Panel Mulls Medicare Payment, Prior Authorization Bills
- Petition Watch: Abortion Protests, Workers' Comp & Sanctions
- IP Forecast: NXP-Impinj Patent Battle Heads To Waco
- FDA Issues New COVID Vaccine Development Guidance
- Bankrupt Rite Aid's New Directors To Earn $50K Per Month
- 5th Circ. Asks Illumina, FTC For Update On EU Order's Impact
- Biotech Co. Exec Gets 8 Years Over Blood Test Fraud
- Biden Admin Plans Stricter Toxic Chemical Evaluations
- PFAS-Tainted Water Sold By Conn. Utilities, Customers Allege
- FCA Suits Anticipated As COVID Criminal Cases Wrap Up
- How To Navigate The FTC's New Private Equity Frontier
- Bovine Breeding Co. Wins Remand After PTAB Loss
- Calif. Man Admits Guilt In Pfizer Insider Trading Scheme
- 'Unacceptable Gamesmanship' Gets Calif. IP Atty Disbarred
- Newman Suspension Shows Need For Judicial Reform
- Faegre Drinker Adds Attys With Health Care Experience
- Rite Aid Cites 'Substantial Doubt' It Can Stay In Business
- MVP: Sullivan & Cromwell's Matt Hurd
- Novartis Airs Mea Culpa As 2nd Circ. Probes Kickback Theory
- Calif. Embraces Bold New Climate, Consumer, Labor Laws
- Natera Hid Prenatal Test Authorization Scheme, Investor Says
- Trans Adults, Minors Get Class Cert. In Fla. Health Care Fight
- Philips Medical Is Told To Pay $2.5M Treble Damages To Rival
- 6 Lewis Brisbois Attys Join Wilson Elser In Pacific NW Growth
- Doctor Staffing Cos. To Pay $4.3M To End Mich. FCA Suits
- Ohio Broker Gets 10 Years For Medical Lab Investment Scam
- Judge Invites Tipster To Fix Medicaid Rebate FCA Suit
- Sorrento Cleared For $20M JV Sale In Ch. 11 Case
- J&J Floats 3rd Bankruptcy For Talc Claims On Earnings Call
- Teva Loses Challenge Of €60M Pay-For-Delay Fine
- ArcherDX Renews Bid To Ax $19M Patent Verdict
- ITC Has Few Answers On How IP Constrains COVID Treatments
- JPML Should Say If Foam Co. Coverage Suit Belongs In MDL
- Ex-Navy Officer Gets 2.5 Years For $2M Insurance Fraud
- An Overview Of Congress' Proposed Drug Shortage Solutions
- McCarter & English Urges Judge To Reject Ex-Client's Retrial
- 5th Circ. Upends Louisiana Judge's Forced-Medication Ruling
- Counsel For J&J Talc Unit Ch. 11 Committee Fight For Fees
- Regeneron Kickback Issue Likely To Follow Teva To 1st Circ.
- Mich. Senate Pushes Drugmaker Immunity Repeal Forward
- MVP: Paul Weiss' Krishna Veeraraghavan
- Icahn Goes After Illumina's Board In Del. Chancery Court
- Abortion Foes Ask For Full Review Or Nothing In Drug Appeal
- Community Pharmacist Group Lawyers Up To Take On PBMs
- Express Scripts Urges 9th Circ.: Keep Insulin Suit In Fed Court
- Pfizer To Pay $2M In Back Wages To Women Under DOL Deal
- FDA Softens Enforcement Of Blood Donation Rules
- NJ County Says Feds Rushed Flawed Ocean Wind 1 Approvals
- Walgreens Fights Crowell Bid To Ax Suit Over Humana Award
- Thermo Fisher To Acquire Sweden's Olink In $3.1B Deal
- Stem Cell Research Biz Loses $7M Atty Fee Bid In Patent Fight
- Sterigenics To Pay $35M To End Atlanta Suits Ahead Of Trial
- Considerations And Calculations For DOJ Clawback Program
- MVP: Paul Hastings' Eric Dittmann
- Biotech Investors Get Final Nod For $1.4M Settlement
- Catching Up With Delaware's Chancery Court
- US, EU Industry Groups Call For Openness In Summit Talks
- J&J's DePuy Wins Seattle Trial Of Faulty Knee Implant Claims
- Insurer Says Faulty Dehumidifier Caused $900K Fire Damage
- Arthrex Prevails In PTAB Challenges To Joint Repair Patents
- Verrill Dana Adds Seasoned Health Care Lawyer
- Lyra Taps New CLO As It Looks To Launch Nasal Implants
- Biotech Firm, Energy Producer Eye IPOs Totaling $450M
- SEC's Life Sciences Actions Utilize Novel Tools And Theories
- Smart Medical Device Maker Inks $60M SPAC Merger
- Feds Rip Ex-NJ Firefighter's $50M Drug Fraud Sentence Fight
- What Case Trends Reveal About Life Sciences Results At ITC
- ESG Around The World: Japan
- Investors In Maker Of Failed COVID Test Want Class Certified
- Pharma Co. Investors Want Docs On Post-Merger Payments
- How And Why Your Firm Should Implement Fixed-Fee Billing
- FDA Sends Proposed Menthol Ban To White House
- Supreme Court Won't Hear Milk Vitamin Patent Eligibility Case
- Womble Bond Brings On IP Team From Dentons In San Diego
- Munger Tolles Faces DQ Bid In GenapSys' Paul Hastings Suit
- PTAB Backs Edwards In Colibri Heart Valve Patent Challenge
- MVP: Davis Polk's David Bauer
- Potential Broader Effects Of FDA's Lab-Developed Test Rule
- Ex-FDA Regulatory Atty Joins Faegre Drinker In DC
- Rite Aid Taps Into DIP Loans, Sets Fast Ch. 11 Sale Schedule
- Kirkland's Jim Hurst Returns After Stint Away From Law
- DOJ Inks Settlement With Fla. Doc In Fentanyl Kickback Case
- Cancer Co. Seeks Ch. 7 Conversion Before Money Runs Out
- Pharma Supplier Says Ex-Sales Chief Broke Noncompete
- Pot License Denial Isn't 'Contested Case,' Ga. Panel Says
- AMA, Women's Clinic Drop ND 'Abortion Reversal' Challenge
- Supreme Court Deluged With Calls To Hear Abortion Pill Battle
- Calif. Atty Gets 6 Years For Selling $157M Of Unlicensed Drugs
- Pharma Co. RevitaLid Can Tap Part Of $17.5M Ch. 11 Funding
- 11th Circ. Revives Prisoner's Claims He Never Got Hep C Meds
- Attys Can't Contest Rule They Helped Revise, Panel Says
- Monkey Vet Says He Was Fired For Euthanasia Attempt Report
- Humana Beats Walgreens' Claims Over Crowell & Moring
- REIT Doesn't Owe LA Fitness Rent Refund, Panel Says
- Judicial Independence Needs Defense Amid Political Threats
- 2 New Ways FDA Is Changing Lab-Developed Test Regulation
- UK Litigation Roundup: Here's What You Missed In London
- FDI Considerations For UK Venture Capital Transactions
- Fed. Circ. Backs PTAB's Refusal To Invalidate Polymer IP
- Sorrento Seeks Quick Timeline On Process For Ch. 11 Plan
- Ex-Stimwave CEO Can't Toss Fraud Indictment
- Why Talc Claimants' Experts Should Fear New Jersey Courts
- Fed. Circ. Warned USPTO Ruling Threatens Antibody Patents
- Barnes & Thornburg Adds 2 Health Care Finance Attorneys
- GSK Unit Urges Chancery To Save Nebraska Patent Suit
- Eli Lilly Continues Migraine IP Wins Over Teva With PTAB Ax
- Okla. Pharmacy Owner Padded Pockets in Prescription Scam
- How Life Sciences Cos. Can Prevent Securities Class Actions
- How Law Firms Can Use Account-Based Marketing Strategies
- FDA Orders RJ Reynolds Flavored E-Cigs Off Market
- 11 Ways Senate Bill Would Alter PTAB Practice
- Chancery Rejects DMK Investor's Bid To Bar Annual Meeting
- Ill. Judge OKs Deal Over False Pharmacy Board Exam Failures
- Pharma Biz Says Fox Rothschild Atty Gave Secrets To Rival
- J&J Talc Unit Blasts $1.3M Ch. 11 Fee Claims By Talc Tort Firms
- Ill. Panel Won't Revive Nurse's Suit Over Hospital Vax Policy
- Navigating Over-The-Counter Product Ads After FTC Warning
- Swedish Medical Device Maker Buys US Biz For $320M
- RVL Pharma Units Hit Ch. 11 In Del. With Lender Handoff Plan
- EU Orders Illumina To Sell Off Grail
- 1st Circ. Resurrects Investors' Fraud Claim Against Biogen
- DNA Sequencing Patent Survives Guardant PTAB Challenge
- Investors Alleging $51M Loss To Lead Pharma Co. Suit
- Leaders of Drug Co. Hurt Stock With Lies, Suit Says
- Amyris Junior Creditors Waived Ch. 11 DIP Lien Protection
- FDA Launches New Digital Health Advisory Committee
- A Reminder For Drug Cos. To Confirm Orange Book Listings
- Split 9th Circ. Won't Revive IRhythm Securities Fraud Suit
- Strategic Succession Planning At Law Firms Is Crucial
- Sorrento To Sell JV Stake For $20M In 'Urgent' Bid For Cash
- Think Tanks Fight Dismissal Of $39B Debt Relief Challenge
- 2 Firms To Lead Investor Suit Over Myovant-Sumitomo Deal
- What An NCAA Drug Test Change Could Mean For Cannabis
- Pfizer Agrees To Shell Out $50M To Exit EpiPen Antitrust Suit
- Judge Mostly Clears Ex-Nestle Skin Biz In Dummy Head Fight
- Imaging Company To Pay $85M Over Doctor Kickback Scheme
- Adamis Investor Seeks Chancery Order To Block Board Vote
- Arrayit Exec Rips 15-Year Bid For COVID Fraud, Seeks 4 Years
- Medtech Co. Haemonetics Inks $253M Deal To Buy OpSens
- Florida Man Convicted In $67M Medicare Genetic Test Scam
- Fla. High Court To Review Abortion Rights Ballot Measure
- Calif. Gov. Vetoes Psychedelics Decriminalization Bill
- Consumer Suit Over Anti-Aging Supplements Moved To Utah
- FDA's Lab-Developed Test Rule Faces High Hurdles
- Catching Up With Delaware's Chancery Court
- Calif. Gov. Signs Law To Require Prescription Error Reporting
- Email Flub In Opioid MDL No Basis For Master's Removal
- Lipitor Hearing Punted As Ranbaxy Counsel 'Trapped' In Israel
- Justices Could Use Purdue To Resolve Related Circuit Split
- High Court Won't Hear Appeal Over FDA's E-Cig Denial
- Tech Firm Hit With Wage Suit Over 'Retroactive' Layoffs
- Cooley Adds Foley & Lardner Life Sciences Atty In San Diego
- Mapping Big Pharma's Blitz On Medicare Drug Price Talks
- Pharma Experts See Split On Effect Of Drug Price Negotiations
- Cooley Attys Savor Amgen-Horizon Close After FTC Battle
- J&J Unit Wants To Slash $27M Fees For Talc Claim Lawyers
- Gordon & Rees Boosts Its New Mexico Footprint
- DEA Issues 2nd Extension Of Telehealth Prescription Rule
- FDA Not Happy With Status Of Philips CPAP Recall
- FTC's Health Co. Suit Indicates Agency's Private Equity Focus
- Walgreens Sold 'Wholly Ineffective' Decongestants, Suit Says
- 2 Firms To Rep BioXcel Investors In Suit Against AI Drugmaker
- 'Lead Compound' Rule For Drug Patents Leads Courts Astray
- What Marijuana Status Change Would Mean For Industry
- Don't Miss It: Skadden, Latham Lead Hot Deals
- IP Forecast: Novartis To Fight Antitrust Row Over Drug Patent
- Biotech Co. Drops MRNA Patent Suit Against Pfizer, BioNTech
- Pharma Cos. Form Coalition To Fight FTC Merger Approach
- Women's Health Care Co. Raises $34M In Series B Round
- HHS Wants Quick Review Of Research Misconduct Allegations
- Top 4 Antitrust Enforcement Issues In Health Care Today
- Biologics Co. Execs Hit With Suit Over Revenue Controls
- 6 Lessons From Direct Selling Industry's Win Over FTC
- Calif. Climate Disclosure Bills Promise Challenges For Cos.
- Nurse Says OT Claims Don't Mimic Those In State Court Suit
- Maximizing Law Firm Profitability In Uncertain Times
- The Patent Eligibility Restoration Act Merits Deliberation
- Amyris Says $190M Ch. 11 Loan Should Get Senior Lien
- Justices Urged To Halt All In-House Cases Until Congress Acts
- Never Mind: Ozempic Patents Not Fully In The Clear At PTAB
- Zymergen Files Liquidation Plan As Ch. 11 Case Begins In Del.
- Fla. Jury Finds 2 Guilty In $93M Medicare Home Health Scam
- States Back Off Bid To Block Sandoz Spinoff In Antitrust Case
- Covington Brings On Ex-Mintz Capital Markets Pro In NY
- FDA Floats Advice For Developing Stimulant Addiction Drugs
- Ex-Eli Lilly Worker Settles Whistleblower Suit
- 8 Chinese Firms Indicted For Shipping Fentanyl Chemicals
- Teva Urges Court To Block Colo. EpiPen Access Program
- Chubb Unit, Wholesaler Close To Settling Opioid Coverage Row
- Mintz, Fenwick Mold Deal For $1B Life Sciences Tools Co.
- Lawmakers Bash UnitedHealth's M&A Tactics In Letter To DOJ
- Trending At The PTAB: Changes To Director Review, Hearings
- Major Drugmakers Set To Negotiate Medicare Drug Prices
- 11th. Circ. Told That Fla. Pelvic Mesh Suit Was Time-Barred
- LabCorp Hit With Meal Breaks, OT Class Action In Wash.
- Novo Nordisk Dodges PTAB Review On Lucrative Ozempic IP
- Colo. Woman Sues Prosthetic Co. Alleging Hip Implant Defect
- NJ Appeals Court Reverses $224M Talc Verdict Against J&J
- Justices Won't Hear Ex-MLB Player's Substance Ban Case
- Crowell Aims To Sink Walgreens Suit Over Humana Conflict
- 7 Common Compliance Pitfalls For Multistate Pharmacies
- Kirkland, Skadden Lead Eli Lilly's $1.4B Point Biopharma Buy
- AstraZeneca Inks $425M Deal To End Acid-Reflux Drug Claims
- Virginia Attorney's Office Reaches Nearly $1M FCA Settlement
- Novo Nordisk Joins Fight With HHS Over Drug Price Talks
- NuVasive Grills Ex-Exec On Jump To Competitor
- High Court Won't Review Abortion Foes' Bid In Video Case
- Sutter Health Emails Reveal Billing Confusion In $519M Trial
- Vitamin Co. Can't Escape 'Natural' Supplement False Ad Suit
- Genomic Health To Pay $32.5M In Medicare Billing FCA Deal
- Drug Co. Investors Settle Clinical Trial Suit For $2.3M
- Uncertainty Still Looms For IPOs Despite Shutdown Reprieve
- Shkreli-Tied Vyera Pharmaceuticals Gets Ch. 11 Plan OK
- 5th Circ. Ruling Reminds Attys That CBP Can Search Devices
- High Court Seeks SG Opinion In Pharma Terror-Funding Suit
- FDA's Drug Software Draft Guidance Raises New Questions
- Insurer Must Face Claim In Crowell & Moring Imbroglio
- Another Alice Appeal Bites The Dust At High Court
- Finnegan Rehires 2 IP Attys In Boston, DC
- Catching Up With Delaware's Chancery Court
- ESG Around The World: European Union
- Minerals Technologies Puts Barretts Talc Unit Into Bankruptcy
- High Court Turns Away Colgate's Challenge To ERISA Case
- Justices Reject Plea To Ease FCA Kickback Standard
- Supreme Court Rejects Diagnostics IP Challenge
- Law360 MVP Awards Go To 171 Attys At 76 Firms
- Planned Parenthood Gets Halt Of NC Abortion Limits, For Now